Nkarta (NKTX) Non Operating Income (2019 - 2026)
Nkarta's Non Operating Income was $2.76 million in Q2 2026, down 34.4% from $4.21 million a year earlier and down 9.3% from the prior quarter.
Powered by 
Analysis
Nkarta (NKTX) Non Operating Income (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Nkarta's Non Operating Income was $14.93 million through Jun 30, 2026, down 22.4% year-over-year; for FY2025, it came in at $17.91 million, down 7.7% from FY2024.
- In earlier years, Non Operating Income was $19.4 million in FY2024 (+37.1%), $14.15 million in FY2023 (+176.5%), $5.12 million in FY2022 and $354,000 in FY2021.
- The Q2 2026 figure marks the lowest quarterly Non Operating Income since Q4 2022.
- Compared with a year earlier, Non Operating Income has declined for three straight quarters, with growth averaging 1.9% over the last eight quarters.
- The best year-over-year quarter for Non Operating Income over five years was Q2 2022 (growth of 596.0%); the worst was Q2 2026 (a decline of 34.4%).
- Per Business Quant data, NKTX's Non Operating Income in the three quarters before Q2 2026 was $3.04 million (Q1 2026), $3.55 million (Q4 2025) and $5.57 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Nkarta | 96.80 Mn | -1.37 Bn | - | 2.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.45 Mn |
| Jun 30, 2026 | 2.76 Mn |
| Mar 31, 2026 | 3.04 Mn |
| Dec 31, 2025 | 3.55 Mn |
| Sep 30, 2025 | 5.57 Mn |
| Jun 30, 2025 | 4.21 Mn |
| Mar 31, 2025 | 4.58 Mn |
| Dec 31, 2024 | 4.99 Mn |
| Sep 30, 2024 | 5.45 Mn |
| Jun 30, 2024 | 5.72 Mn |
| Mar 31, 2024 | 3.24 Mn |
| Dec 31, 2023 | 3.43 Mn |
| Sep 30, 2023 | 3.65 Mn |
| Jun 30, 2023 | 3.57 Mn |
| Mar 31, 2023 | 3.50 Mn |
| Dec 31, 2022 | 2.40 Mn |
| Sep 30, 2022 | 1.92 Mn |
| Jun 30, 2022 | 689,000.00 |
| Mar 31, 2022 | 111,000.00 |
| Dec 31, 2021 | 73,000.00 |
API Access
Nkarta Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=NKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "NKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=NKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();